As we discussed earlier, a variety of artificial intelligence (AI) technologies exist and are being used in biopharma (e.g., discovery and development of drugs, optimization of clinical trial design, identification of novel...more
Dr. Stephen Thaler created an AI algorithm (named DABUS) that includes multiple neural networks trained in different linguistic subspaces that connect dynamically in a manner based on controlled chaos. DABUS also includes a...more
Dr. Stephen Thaler created an artificial-intelligence algorithm – named Device for the Autonomous Bootstrapping of Unified Sentience (DABUS) – that includes multiple neural networks (each trained in a given linguistic...more
A variety of artificial intelligence (AI) technologies exist and are being used in biopharma (e.g., discovery and development of drugs, optimization of clinical trial design, identification of novel biological targets and...more
Kilpatrick Townsend’s Kate Gaudry and Rodney Rothwell recently participated in the Association of Corporate Counsel’s National Capital Region’s Summer Series: “Protecting Artificial Intelligence (AI) Innovations – Unique...more
Patent activity provides an important signal that is helpful in identifying and forecasting industry trends including the development of new products and services. It can predict the future focus of individual competitors...more
5/1/2019
/ Artificial Intelligence ,
Blockchain ,
FinTech ,
Intellectual Property Protection ,
Medical Devices ,
Patent Applications ,
Patent Infringement ,
Patent Litigation ,
Patents ,
Pharmaceutical Industry ,
Popular
Kilpatrick Townsend attorney Kate Gaudry recently presented on “Eligibility-Rejection Trends: Within and Beyond Business-Method Art Units” as part of the Landslide Webinar Series.
Key takeaways from Dr. Gaudry’s...more